Loblaw Co (L.TO):

Summary

  • L.TO rose slightly over the past 10 trading sessions: C$64.59 on Jun. 15 → C$65.93 on Jun. 26 = +C$1.34 / +2.1%.
  • The move was not smooth: it fell to C$63.38 on Jun. 22, then rebounded strongly on Jun. 23–24.
  • Main driver: defensive rotation into staples, helped by Loblaw’s stable grocery/pharmacy earnings profile.
  • Q1 fundamentals support the stock: revenue +4.2%, Food same-store sales +2.4%, Drug same-store sales +4.1%, adjusted EPS +10.6%.
  • Upside is limited by valuation: Yahoo showed P/E ~29x and a 52-week range of C$52.92–C$69.59.

10-Day Price Action

DateCloseDaily Move
Jun. 15C$64.59-0.63%
Jun. 16C$64.88+0.45%
Jun. 17C$64.69-0.29%
Jun. 18C$64.76+0.11%
Jun. 19C$64.09-1.03%
Jun. 22C$63.38-1.11%
Jun. 23C$64.77+2.19%
Jun. 24C$66.20+2.21%
Jun. 25C$66.09-0.17%
Jun. 26C$65.93-0.24%

Source: Investing.com historical data.

Why It Moved

1. Defensive rotation

Loblaw benefited when money moved into consumer staples during broader TSX volatility. On Jun. 24, the TSX hit a 13-day low as oil and gold fell, pressuring energy and materials. Staples were relatively attractive because grocery and pharmacy earnings are less cyclical.

2. Fundamentals are steady

Loblaw’s Q1 numbers were strong enough to support the stock:

MetricQ1 2026Impact
Retail revenueC$14.484B, +4.2%Positive
Food same-store sales+2.4%Stable
Drug same-store sales+4.1%Positive
E-commerce sales+20.3%Positive
Retail adjusted EBITDAC$1.607B, +6.5%Positive
Adjusted EPSC$0.52, +10.6%Positive
Dividend+10%Supportive

Source: Loblaw Q1 release.

3. Rebound after weakness

The stock dropped from C$65.00 on Jun. 12 to C$63.38 on Jun. 22, then recovered to C$66.20 by Jun. 24. That looks like a short-term mean-reversion bounce, not a new earnings event.

Valuation Logic

FactorImpact
Defensive grocery/pharmacy earningsSupports premium valuation
Same-store sales positiveSupports trend
Buybacks and dividend growthSupports EPS/share
P/E near 29xLimits upside
Close to 52-week highProfit-taking risk

Scenarios

ScenarioTriggerPrice implication
BullHolds above C$66 and staples rotation continuesRetest C$68–70
BaseStable earnings, valuation caps upsideRange C$64–67
BearProfit-taking or weak consumer dataPullback toward C$63–64

Actionable Takeaways

L.TO’s 10-day move was a modest defensive-sector rebound. The stock recovered after a dip because Loblaw has stable grocery/pharmacy earnings, positive same-store sales, buybacks, and dividend growth. The main constraint is valuation: at roughly 29x earnings, further upside needs continued earnings growth, not just defensive rotation.

Comments

Leave a Reply